Proteome Profiling Services Market, 2020-2030

Proteome Profiling Services Market, 2020-2030

Proteins are complex biomolecules that are involved in a number of essential functions in living organisms. Proteome profiling refers to the large-scale, high-throughput analysis of biological samples for the detection, identification, and functional characterization of resident proteins. The process includes the study of polypeptide structure, expression, function, protein-protein interactions, and post translational modifications (PTMs). , With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process and disease diagnosis. It is worth highlighting that various types of proteomic analyses are being used in diagnosis, severity determination and therapy development efforts against COVID-19. In fact, one study reported the potential implications of the urinary proteome in understanding the pathophysiology of the disease.

Currently, the demand for proteome profiling is high, given the growing pipeline of peptide therapeutics. Although some pharmaceutical companies have invested in building in-house proteomics research capabilities, significant capital investments and specialized requirements renders this approach prohibitive for most stakeholders. This has created a demand for service provider companies with expertise in this field. In fact, since 2000, more than 85 players offering proteome profiling services have been incorporated. Amidst growing competition in the proteome profiling services market, availability of cutting-edge tools and the latest analytical serves to differentiate the offerings of stakeholders in this upcoming industry. Consequently, several service providers have actively begun expanding their respective service portfolios, either through strategic acquisitions or entering into service alliances with other specialty companies. Over time, several players have developed end-to-end capabilities, ranging from sample preparation to in silico analysis and post translational modifications-related expertise. As a consequence, the contract services market catering to this segment of the pharmaceutical industry, is anticipated to witness substantial growth in the coming years.

SCOPE OF THE REPORT
The ‘Proteome Profiling Services Market, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:
 A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purification), service(s) offered for proteome profiling (analysis of post translational modifications, protein characterization, in silico analysis and protein sequencing), other service(s) offered (protein-protein interaction analysis, biomarker discovery, biological pathway identification, impurity profile analysis, bio imaging of proteins), type of product profiled (proteins and peptides), type of sample(s) used (cells, tissues, plasma, serum, urine, cerebrospinal fluid (d), blood, saliva, cyst fluid and others) and type of application (drug discovery, disease diagnosis and others).
 Elaborate profiles of the prominent players (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific and rest of the world. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook.
 A competitiveness analysis of proteome profiling service providers, taking into consideration the supplier strength (based on company size and its experience in this field), service strength (based on number of pre-proteome profiling service(s) offered, number of proteome profiling service(s) offered, number of other service(s) offered, number of product types profiled and number of applications) and number of samples profiled (which is depicted by size of the bubble).
 An analysis of the partnerships that have been inked by stakeholders in the proteome profiling services domain, during the time period 2014-2020 (till April), covering different partnership models, such as service alliances, acquisitions, technology licensing, R&D agreements and research agreements.
 An elaborate discussion on various factors contributing to the high price of proteome profiling. It features different pricing models of proteome profiling services based on number of proteins / samples processed, proteome profiling steps and sample types.
 A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework; it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
 A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market. In addition, it features various strategies that different companies have adopted / might adopt in order to mitigate the challenges affiliated to the current global crisis.

One of the key objectives of the report was to estimate the existing market size and the future growth potential of the proteome profiling services. Based on multiple parameters, such as projected growth of the overall proteomics market and extend of outsourcing, we have developed informed estimates on the financial evolution of the market, over the period 2020-2030. The report also provides details on the likely distribution of the current and forecasted opportunity across [A] type of application (drug discovery, disease diagnosis and others) [B] type of sponsor (pharmaceutical companies, research and academics institutes and CROs) [C] key geographical regions (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:
 James Fedrick, President and Chief Executive Officer, Rockland Immunochemicals
 Anton IIliuk, Chief technology Officer, Tymora Analytical Operations

RESEARCH METHODOLOGY
The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:
 Annual reports
 Investor presentations
 SEC filings
 Industry databases
 News releases from company websites
 Government policy documents
 Industry analysts’ views

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

KEY QUESTIONS ANSWERED
 Who are the leading proteome profiling service providers?
 What kind of partnership models are presently being used by stakeholders in this industry?
 What is the impact of COVID-19 on the demand for proteome profiling services?
 What factors are likely to influence the evolution of this upcoming market?
 How is the current and future opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES
Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the proteome profiling services market and its likely evolution in the short-mid term and long term.

Chapter 3 provides a general introduction to proteome profiling services, featuring detailed description on various proteome profiling steps, the different types of proteome profiling technologies (conventional and advanced), various proteome profiling applications and the key challenges associated with profiling proteins. Additionally, it provides details related to the growing need for outsourcing of such services.

Chapter 4 provides an overview of the proteome profiling services market landscape. It features an in-depth analysis of over 210 players that claim to offer proteome profiling services, based on a number of parameters, such as type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purification), service(s) offered for proteome profiling (analysis of post translational modifications, protein characterization, in silico analysis and protein sequencing), other service(s) offered (protein-protein interaction analysis, biomarker discovery, biological pathway identification, impurity profile analysis, bio imaging of proteins), type of product profiled (proteins and peptides), type of sample(s) used (cells, tissues, plasma, serum, urine, CSF, blood, saliva, cyst fluid and others) and type of application (drug discovery, disease diagnosis and others).

Chapter 5 provides detailed profiles of players that are actively involved in the proteome profiling services market in North America. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook.

Chapter 6 provides detailed profiles of the key players that are active in the proteome profiling services market in Europe. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook.

Chapter 7 provides detailed profiles of the key players that are active in the proteome profiling services market in Asia Pacific and rest of the world. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook.

Chapter 8 features a competitiveness analysis of proteome profiling service providers, taking into consideration supplier strength (based on company size and its experience in this field), service strength (based on number of pre-proteome profiling service(s) offered, number of proteome profiling service(s) offered, number of other service(s) offered, number of product types profiled and number of applications) and number of samples profiled (which is depicted by size of the bubble).

Chapter 9 features an analysis of the various partnerships and collaborations that have been inked amongst players in this domain, in the time period 2014-2020 (till April). It provides a brief description on the various types of partnership models (which include service alliances, acquisitions, technology licensing, R&D agreements and research agreements) that have been adopted by stakeholders in this domain. Further, it includes analyses based on year of partnership, type of partnership, type of service mentioned in the agreement, type of application mentioned in the agreement and most active players. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 10 features an elaborate discussion on various factors contributing to the high price of proteome profiling. It features different pricing models of proteome profiling services based on number of proteins / samples processed, proteome profiling steps and sample types.

Chapter 11 provides a discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework. In addition, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.

Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the proteome profiling services market till the year 2030. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] type of application (drug discovery, disease diagnosis and others) [B] type of sponsor (pharmaceutical companies, research and academics institutes and CROs) [C] key geographical regions (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Chapter 13 highlights the impact of the COVID-19 pandemic on the overall proteome profiling services market. In addition, it features various strategies that different companies have adopted / might adopt in order to mitigate the challenges affiliated to the current global crisis.

Chapter 14 is a summary of the overall report, wherein we have mentioned all the key facts and figures described in the previous chapters. The chapter also highlights important evolutionary trends that were identified during the course of the study and are expected to influence the future of the proteome profiling services market.

Chapter 15 is a collection of interview transcripts of the discussions held with key stakeholders in the industry. We have presented details of interviews held with James Fedrick (President and Chief Executive Officer, Rockland Immunochemicals) and Anton IIliuk, (Chief technology Officer, Tymora Analytical Operations)

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

LIST OF COMPANIES AND ORGANIZATIONS

The following companies and organizations have been mentioned in the report.
1. Abzena
2. Advanced Biomart
3. Agilent Technologies
4. Alphalyse
5. Applied Biomics
6. ARVYS Proteins
7. Autonomous University of Barcelona
8. AVMBioMed
9. AxisPharm
10. Baylor College of Medicine
11. Beth Israel Deaconess Medical Center
12. BGI
13. BioAnalytix
14. Biognosys
15. BioMediTech
16. BioPharmaSpec
17. Bioproximity
18. BioResource Biotech
19. Bio-Synthesis
20. BIOTOOLS
21. BioXpedia
22. Boston Analytical
23. Bruker
24. Buck Institute for Research on Aging
25. Caprion Biosciences
26. Cedars-Sinai
27. Cell Signaling Technology
28. Center for Cooperative Research in Biosciences
29. Central European Institute of Technology
30. Centre for Cellular and Molecular Biology
31. Centre for Cellular And Molecular Platforms
32. Centre for Proteomic and Genomic Research
33. Centre for Omic Sciences
34. Charité-Universitätsmedizin Berlin
35. Chemily Glycoscience
36. Cleveland Clinic Lerner Research Institute
37. Cogentech
38. Columbia University
39. Cornell University
40. CPR Pharma Services
41. Creative Bioarray
42. Creative Proteomics
43. Cytomics
44. Dana-Farber Cancer Institute
45. David H. Koch Institute for Integrative Cancer Research
46. DC Biosciences
47. Dualsystems Biotech
48. Duke Center for Genomic and Computational Biology
49. EirGenix
50. Emory University
51. European Molecular Biology Laboratory
52. First BASE Laboratories
53. Focus Proteomics
54. Fred Hutchinson Cancer Research Center
55. Full Moon BioSystems
56. Functional Genomics Center Zurich
57. Genei Laboratories
58. Genentech
59. GenScript
60. GenxbiO Health Sciences
61. GHO Capital
62. Gustave Roussy
63. Haematologic Technologies
64. Harvard University
65. HistoGeneX
66. HT-Labs
67. IDeA National Resource for Quantitative Proteomics
68. i-DNA Biotechnology
69. Indian Institute of Technology, Madras
70. Indiana University School of Medicine
71. Indivumed
72. Institute of Molecular Biology
73. Institut Curie
74. Institute of Bioinformatics
75. Institute for Research in Immunology and Cancer
76. Instiut Pasteur
77. Intertek
78. ISAS
79. ITSI-BIOSCIENCES
80. JadeBio
81. Janssen
82. Jewish General Hospital
83. John Innes Centre
84. JPT Peptide Technologies
85. Karolinska Institutet
86. Keck School of Medicine of USC
87. Kinexus
88. Leadgene Biomedical
89. Leibniz Institute on Aging - Fritz Lipmann Institute
90. LI-COR Biosciences
91. Ludwig Maximilian University of Munich
92. Lynx Biosciences
93. Macquarie University
94. MatTek
95. Max Perutz Labs
96. Max Planck Institute
97. Max Planck Institute of Biochemistry
98. Max Planck Institute of Molecular Cell Biology and Genetics
99. Mayo Clinic
100. MD Anderson Cancer Center
101. Medical University of South Carolina
102. Medicines Discovery Catapult
103. Medigene
104. MELISA Institute
105. Memorial Sloan Kettering Cancer Center
106. Monash University
107. Montreal Clinical Research Institute
108. Moredun Research Institute
109. Morehouse School of Medicine
110. MS Bioworks
111. MtoZ Biolabs
112. NanoString Technologies
113. Nanoxis Consulting
114. National Cancer Institute
115. National Resource for Translational and Developmental Proteomics
116. N-Cell Technology
117. NEC Solution Innovators
118. Neuro-Sys
119. Nexelis
120. NH DyeAGNOSTICS
121. NMI TT Pharmaservices
122. Norwegian University of Science and Technology
123. NovaBioAssays
124. Novartis
125. Novatia
126. Nucro-Technics
127. Ocean Ridge Biosciences
128. Ohio State University
129. Oregon Health & Science University
130. Ospedale San Raffaele
131. Parker H. Petit Institute for Bioengineering and Bioscience
132. Peak Proteins
133. Pelago Bioscience
134. PEPperPRINT
135. Polish Academy of Sciences
136. Poochon Scientific
137. Princeton University
138. ProFI Proteomics
139. Protagen Protein Services
140. Protea Biosciences
141. Protein Metrics
142. ProteinCT Biotechnologies
143. Proteome Factory
144. ProteomeTech
145. Proteomics International
146. Proteos
147. ProtTech
148. PTM Biolabs
149. Radboud University
150. Rajiv Gandhi Centre for Biotechnology
151. Research Center of CHU de Quebec Universite Laval
152. Retrogenix
153. Rockland Immunochemicals
154. Rutgers New Jersey Medical School
155. Saint Louis University
156. Sandor LifeSciences
157. SciGenom
158. SciLifeLab
159. Sciomics
160. Scripps Research
161. SGS
162. Shanghai Applied Protein Technology
163. Shantani Proteome Analytics
164. Smoler Proteomics Center
165. SomaLogic
166. Sanford Burnhum Prebys Medical Discovery Institute
167. Stratech Scientific
168. Swiss Federal Institute of Technology Lausanne
169. SYMBIOSIS
170. System Biosciences
171. Tata Institute of Fundamental Research
172. tebu-bio
173. Temple University
174. Texas A&M University
175. The Institute of Plant Biochemistry and Photosynthesis
176. The National Institute for Cellular Biotechnology
177. THE PROTEIN WORKS
178. The University of Tennessee Health Science Center
179. The University of Texas Health Science Center at Houston
180. The University of Texas System
181. The Wistar Institute
182. Thermo Fisher Scientific
183. Translational Research Institute Australia
184. Tymora Analytical Operations
185. Ubiquigent
186. UCLA Pasarow Mass Spectrometry Laboratory
187. UCLA Proteome Research Center
188. Universiti Sains Malaysia
189. University of Oklahoma
190. University of Aberdeen
191. University of Adelaide
192. University of Bern
193. University of Birmingham
194. University of Bristol
195. University of Calgary
196. University of California, Davis
197. University of California, Irvine School of Medicine
198. University of Cambridge
199. University of Cologne
200. University of Dundee
201. University of Edinburgh
202. University of Florida Interdisciplinary Center for Biotechnology Research
203. University of Gothenburg
204. University of Heidelberg
205. University of Helsinki
206. University of Hong Kong
207. University of Kentucky
208. University of Lausanne
209. University of Leeds
210. University of Leicester
211. University of Manchester
212. University of Maryland
213. University of Massachusetts Boston
214. University of Michigan Medical School
215. University of Münster
216. University of Nebraska-Lincoln
217. University of North Carolina
218. University of Oslo
219. University of Oulu
220. University of Oxford
221. University of Pennsylvania
222. University of South Dakota
223. University of South Florida
224. University of Texas
225. University of Texas Medical Branch
226. University of Utah
227. University of Victoria Genome British Columbia Proteomics Centre
228. University of Virginia
229. University of Warwick
230. University of Wisconsin-Madison
231. University of York
232. Upstate Medical University
233. UT Southwestern Medical Center
234. Vanderbilt University
235. Vermont Genetics Network
236. Virginia Commonwealth University
237. vivoPharm
238. VProteomics
239. Wake Forest School of Medicine
240. Washington University
241. Waters Corporation
242. Yale School of Medicine
243. Zyagen


1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Proteome Profiling
3.2.1. Proteome Profiling Process
3.2.1.1. Protein Extraction, Separation and Purification
3.2.1.2. Protein Characterization
3.2.1.3. Protein Sequencing
3.2.1.4. Protein Quantification
3.2.1.5. In silico Analysis
3.2.1.6. Analysis of Post Translational Modifications
3.2.2. Proteome Profiling Technologies
3.2.2.1. Type of Proteome Profiling Technologies
3.2.3. Applications of Proteome Profiling
3.2.3.1. Biomarker Discovery
3.2.3.2. Disease Diagnosis
3.2.3.3. Drug Discovery
3.2.3.4. Elucidation of Cause / Propagation of Diseases
3.2.3.5. Toxicoproteomic Studies
3.2.4. Challenges Associated with Proteome Profiling
3.2.5. Outsourcing of Proteome Profiling
3.2.6. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Proteome Profiling Service Providers: Overall Market Landscape
4.2.1. Analysis by Type of Service Provider
4.2.2. Analysis by Year of Establishment
4.2.3. Analysis by Company Size
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Type of Service(s) Offered
4.2.5.1. Analysis by Service(s) Offered for Pre-Proteome Profiling
4.2.5.2. Analysis by Service(s) Offered for Proteome Profiling
4.2.5.3. Analysis by Other Service(s) Offered
4.2.6. Analysis by Type of Product Profiled
4.2.7. Analysis by Type of Sample(s) Used
4.2.8. Analysis by Type of Application
5. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN NORTH AMERICA
5.1. Chapter Overview
5.2. Bioproximity
5.2.1. Company Overview
5.2.2. Proteome Profiling-related Service Offerings
5.2.3. Proteome Profiling Technology
5.2.4. Recent Developments and Future Outlook
5.3. Cell Signaling Technology
5.3.1. Company Overview
5.3.2. Proteome Profiling-related Service Offerings
5.3.3. Proteome Profiling Technology
5.3.4. Recent Developments and Future Outlook
5.4. Creative Biolabs
5.4.1. Company Overview
5.4.2. Proteome Profiling-related Service Offerings
5.4.3. Proteome Profiling Technology
5.4.4. Recent Developments and Future Outlook
5.5. Creative Proteomics
5.5.1. Company Overview
5.5.2. Proteome Profiling-related Service Offerings
5.5.3. Proteome Profiling Technology
5.5.4. Recent Developments and Future Outlook
5.6. Poochon Scientific
5.6.1. Company Overview
5.6.2. Proteome Profiling-related Service Offerings
5.6.3. Proteome Profiling Technology
5.6.4. Recent Developments and Future Outlook
6. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN EUROPE
6.1. Chapter Overview
6.2. Biognosys
6.2.1. Company Overview
6.2.2. Proteome Profiling-related Service Offerings
6.2.3. Proteome Profiling Technology
6.2.4. Recent Developments and Future Outlook
6.3. NMI TT Pharmaservices
6.3.1. Company Overview
6.3.2. Proteome Profiling-related Service Offerings
6.3.3. Proteome Profiling Technology
6.3.4. Recent Developments and Future Outlook
6.4. Proteome Factory
6.4.1. Company Overview
6.4.2. Proteome Profiling-related Service Offerings
6.4.3. Proteome Profiling Technology
6.4.4. Recent Developments and Future Outlook
6.5. Sciomics
6.5.1. Company Overview
6.5.2. Proteome Profiling-related Service Offerings
6.5.3. Proteome Profiling Technology
6.5.4. Recent Developments and Future Outlook
6.6. tebu-bio
6.6.1. Company Overview
6.6.2. Proteome Profiling-related Service Offerings
6.6.3. Proteome Profiling Technology
6.6.4. Recent Developments and Future Outlook
7. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN ASIA PACIFIC AND REST OF THE WORLD:
7.1. Chapter Overview
7.2. BGI
7.2.1. Company Overview
7.2.2. Proteome Profiling-related Service Offerings
7.2.3. Proteome Profiling Technology
7.2.4. Recent Developments and Future Outlook
7.3. Cytomics
7.3.1. Company Overview
7.3.2. Proteome Profiling-related Service Offerings
7.3.3. Proteome Profiling Technology
7.3.4. Recent Developments and Future Outlook
7.4. i-DNA Bioechnology
7.4.1. Company Overview
7.4.2. Proteome Profiling-related Service Offerings
7.4.3. Proteome Profiling Technology
7.4.4. Recent Developments and Future Outlook
7.5. Proteomics International
7.5.1. Company Overview
7.5.2. Proteome Profiling-related Service Offerings
7.5.3. Proteome Profiling Technology
7.5.4. Recent Developments and Future Outlook
7.6. VProteomics
7.6.1. Company Overview
7.6.2. Proteome Profiling-related Service Offerings
7.6.3. Proteome Profiling Technology
7.6.4. Recent Developments and Future Outlook
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Competitiveness Analysis: Industry Players
8.4.1. Competitiveness Analysis: Industry Players based in North America
8.4.2. Competitiveness Analysis: Industry Players based in Europe
8.4.3. Competitiveness Analysis: Industry Players based in Asia Pacific and Rest of the World
8.5. Competitiveness Analysis: Non-Industry Players
8.5.1. Competitiveness Analysis: Non-Industry Players based in North America
8.5.2. Competitiveness Analysis: Non-Industry Players in Europe
8.5.3. Competitiveness Analysis: Non-Industry Players based in Asia Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Proteome Profiling Services Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Service Mentioned in the Agreement
9.3.5. Analysis by Type of Application Mentioned in the Agreement
9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Geographical Analysis
9.3.7.1. Region-wise Distribution
9.3.7.2. Country-wise Distribution
10. COST PRICE ANALYSIS
10.1. Chapter Overview
10.2. Factors Contributing to the High Price of Proteome Profiling
10.3. Price of Proteome Profiling
10.3.1. Pricing Based on Number of Proteins / Samples Processed
10.3.2. Pricing Based on Proteome Profiling Steps
10.3.3. Pricing Based on Sample Type
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Concluding Remarks
12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Assumptions
12.3. Overall Proteome Profiling Services Market, 2020-2030
12.3.1. Proteome Profiling Services Market, 2020-2030: Distribution by Type of Application
12.3.2. Proteome Profiling Services Market, 2020-2030: Distribution by Type of Sponsor
12.3.3. Proteome Profiling Services Market, 2020-2030: Geographical Distribution
12.3.4. Proteome Profiling Services Market in North America, 2020-2030
12.3.5. Proteome Profiling Services Market in Europe, 2020-2030
12.3.6. Proteome Profiling Services Market in Asia Pacific, 2020-2030
12.3.7. Proteome Profiling Services Market in Rest of the World, 2020-2030
13. IMPACT OF THE COVID-19 PANDEMIC ON PROTEOME PROFILING SERVICES MARKET
13.1. Chapter Overview
13.2. Current Opinions and Recuperative Initiatives of Key Players
13.3. Impact on Future Market Opportunity for Proteome Profiling Services Market
14. CONCLUDING REMARKS
14.1. Chapter Overview
14.2. Key Takeaways
15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. Rockland Immunochemicals
15.2.1. Company Snapshot
15.2.2. Interview Transcript: James Fedrick, President and Chief Executive Officer
15.3. Tymora Analytical Operation
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Anton Iliuk, Vice President and Chief Technology Officer
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Proteome Profiling Process
Figure 3.2 Technologies used in Proteome Profiling
Figure 3.3 Proteome Profiling Applications
Figure 3.4 Challenges Associated with Proteome Profiling
Figure 4.1 Proteome Profiling Service Providers: Distribution by Type of Service Provider
Figure 4.2 Proteome Profiling Service Providers: Distribution by Year of Establishment
Figure 4.3 Proteome Profiling Service Providers: Distribution by Company Size
Figure 4.4 Proteome Profiling Service Providers: Distribution by Location of Headquarters
Figure 4.5 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Pre-Proteome Profiling
Figure 4.6 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Proteome Profiling
Figure 4.7 Proteome Profiling Service Providers: Distribution by Type of Other Service(s) Offered
Figure 4.8 Proteome Profiling Service Providers: Distribution by Type of Product Profiled
Figure 4.9 Proteome Profiling Service Providers: Distribution by Type of Sample(s) Used
Figure 4.10 Proteome Profiling Service Providers: Distribution by Type of Application
Figure 8.1 Company Competitiveness Analysis: Industry Players based in North America
Figure 8.2 Company Competitiveness Analysis: Industry Players based in Europe
Figure 8.3 Company Competitiveness Analysis: Industry Players based in Asia Pacific and Rest of the World
Figure 8.4 Company Competitiveness Analysis: Non-Industry Players based in North America
Figure 8.5 Company Competitiveness Analysis: Non-Industry Players based in Europe
Figure 8.6 Company Competitiveness Analysis: Non-Industry Players based in Asia Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service Mentioned in the Agreement
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement and Type of Partnership
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Region-wise Distribution
Figure 9.9 Partnerships and Collaborations: Country-wise Distribution
Figure 11.1 Proteome Profiling Services: SWOT Analysis
Figure 11.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 12.1 Overall Proteome Profiling Services Market, 2020-2020 (USD Billion)
Figure 12.2 Proteome Profiling Services Market: Distribution by Type of Applications, 2020-2030 (USD Billion)
Figure 12.3 Proteome Profiling Services Market: Distribution by Type of Sponsor, 2020-2030 (USD Billion)
Figure 12.4 Proteome Profiling Services Market: Distribution by Key Geographical Regions, 2020 and 2030 (%)
Figure 12.5 Proteome Profiling Services Market in North America, 2020-2030 (USD Billion)
Figure 12.6 Proteome Profiling Services Market in Europe, 2020-2030 (USD Billion)
Figure 12.7 Proteome Profiling Services Market in Asia Pacific, 2020-2030 (USD Billion)
Figure 12.8 Proteome Profiling Services Market in Rest of the World, 2020-2030 (USD Billion)
Figure 13.1 Proteome Profiling Services Market, 2020-2030: COVID Impact Scenario (USD Billion)
LIST OF TABLES
Table 3.1 Proteome Profiling Technologies
Table 4.1 Proteome Profiling Service Providers: List of Service Providers
Table 4.2 Proteome Profiling Service Providers: Information on Type of Service(s) Offered
Table 4.3 Proteome Profiling Service Providers: Information on Type of Sample(s) Used and Type of Application
Table 5.1 Leading Proteome Profiling Service Providers in North America
Table 5.2 Bioproximity: Company Overview
Table 5.3 Bioproximity: Proteome Profiling-related Service Offerings
Table 5.4 Bioproximity: Proteome Profiling Technologies
Table 5.5 Bioproximity: Recent Developments and Future Outlook
Table 5.6 Cell Signaling Technology: Company Overview
Table 5.7 Cell Signaling Technology: Proteome Profiling-related Service Offerings
Table 5.8 Cell Signaling Technology: Proteome Profiling Technologies
Table 5.9 Cell Signaling Technology: Recent Developments and Future Outlook
Table 5.10 Creative Biolabs: Company Overview
Table 5.11 Creative Biolabs: Proteome Profiling-related Service Offerings
Table 5.12 Creative Biolabs: Proteome Profiling Technologies
Table 5.13 Creative Biolabs: Recent Developments and Future Outlook
Table 5.14 Creative Proteomics: Company Overview
Table 5.15 Creative Proteomics: Proteome Profiling-related Service Offerings
Table 5.16 Creative Proteomics: Proteome Profiling Technologies
Table 5.17 Creative Proteomics: Recent Developments and Future Outlook
Table 5.18 Poochon Scientific: Company Overview
Table 5.19 Poochon Scientific: Proteome Profiling-related Service Offerings
Table 5.20 Poochon Scientific: Proteome Profiling Technologies
Table 5.21 Poochon Scientific: Recent Developments and Future Outlook
Table 6.1 Leading Proteome Profiling Service Providers in Europe
Table 6.2 Biognosys: Company Overview
Table 6.3 Biognosys: Proteome Profiling-related Service Offerings
Table 6.4 Biognosys: Proteome Profiling Technologies
Table 6.5 Biognosys: Recent Developments and Future Outlook
Table 6.6 NMI TT Pharmaservices: Company Overview
Table 6.7 NMI TT Pharmaservices: Proteome Profiling-related Service Offerings
Table 6.8 NMI TT Pharmaservices: Proteome Profiling Technologies
Table 6.9 NMI TT Pharmaservices: Recent Developments and Future Outlook
Table 6.10 Proteome Factory: Company Overview
Table 6.11 Proteome Factory: Proteome Profiling-related Service Offerings
Table 6.12 Proteome Factory: Proteome Profiling Technologies
Table 6.13 Proteome Factory: Recent Developments and Future Outlook
Table 6.14 Sciomics: Company Overview
Table 6.15 Sciomics: Proteome Profiling-related Service Offerings
Table 6.16 Sciomics: Proteome Profiling Technologies
Table 6.17 Sciomics: Recent Developments and Future Outlook
Table 6.18 tebu-bio: Company Overview
Table 6.19 tebu-bio: Proteome Profiling-related Service Offerings
Table 6.20 tebu-bio: Proteome Profiling Technologies
Table 6.21 tebu-bio: Recent Developments and Future Outlook
Table 7.1 Leading Proteome Profiling Service Providers in Asia Pacific and Rest of the World
Table 7.2 BGI: Company Overview
Table 7.3 BGI: Proteome Profiling-related Service Offerings
Table 7.4 BGI: Proteome Profiling Technologies
Table 7.5 BGI: Recent Developments and Future Outlook
Table 7.6 Cytomics: Company Overview
Table 7.7 Cytomics: Proteome Profiling-related Service Offerings
Table 7.8 Cytomics: Proteome Profiling Technologies
Table 7.9 Cytomics: Recent Developments and Future Outlook
Table 7.10 i-DNA Bioechnology: Company Overview
Table 7.11 i-DNA Bioechnology: Proteome Profiling-related Service Offerings
Table 7.12 i-DNA Bioechnology: Proteome Profiling Technologies
Table 7.13 i-DNA Bioechnology: Recent Developments and Future Outlook
Table 7.14 Proteomics International: Company Overview
Table 7.15 Proteomics International: Proteome Profiling-related Service Offerings
Table 7.16 Proteomics International: Proteome Profiling Technologies
Table 7.17 Proteomics International: Recent Developments and Future Outlook
Table 7.18 VProteomics: Company Overview
Table 7.19 VProteomics: Proteome Profiling-related Service Offerings
Table 7.20 VProteomics: Proteome Profiling Technologies
Table 7.21 VProteomics: Recent Developments and Future Outlook
Table 9.1 Proteome Profiling Service Providers: List of Partnerships, 2014-2020
Table 10.1 Proteome Profiling Services: Pricing based on Number of Proteins
Table 10.2 Proteome Profiling Services: Pricing based on Number of Samples
Table 10.3 Proteome Profiling Services: Pricing based on Proteome Profiling Steps
Table 10.4 Proteome Profiling Services: Pricing based on Sample Type
Table 14.1 Proteome Profiling Services: Summary of the Report
Table 15.1 Rockland Immunochemicals: Company Snapshot
Table 15.2 Tymora Analytical Operations: Company Snapshot
Table 16.1 Proteome Profiling Service Providers: Distribution by Type of Service Provider
Table 16.2 Proteome Profiling Service Providers: Distribution by Year of Establishment
Table 16.3 Proteome Profiling Service Providers: Distribution by Company Size
Table 16.4 Proteome Profiling Service Providers: Distribution by Location of Headquarters
Table 16.5 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Pre-Proteome Profiling
Table 16.6 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Proteome Profiling
Table 16.7 Proteome Profiling Service Providers: Distribution by Type of Other Service(s) Offered
Table 16.8 Proteome Profiling Service Providers: Distribution by Type of Product Profiled
Table 16.9 Proteome Profiling Service Providers: Distribution by Type of Sample(s) Used
Table 16.10 Proteome Profiling Service Providers: Distribution by Type of Application
Table 16.11 Partnerships and Collaborations: Distribution by Year of Partnership
Table 16.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 16.14 Partnerships and Collaborations: Distribution by Type of Service Mentioned in the Agreement
Table 16.15 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement
Table 16.16 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement and Type of Partnership
Table 16.17 Most Active Players: Distribution by Number of Partnerships
Table 16.18 Partnerships and Collaborations: Region-wise Distribution
Table 16.19 Partnerships and Collaborations: Country-wise Distribution
Table 16.20 Overall Proteome Profiling Services Market, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.21 Proteome Profiling Services Market: Distribution by Type of Applications, 2020-2030 (USD Billion)
Table 16.22 Proteome Profiling Services Market: Distribution by Type of Sponsor (USD Billion), 2020-2030
Table 16.23 Proteome Profiling Services Market: Distribution by Key Geographical Regions, 2020 and 2030 (%)
Table 16.24 Proteome Profiling Services Market in North America, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.25 Proteome Profiling Services Market in Europe, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.26 Proteome Profiling Services Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.27 Proteome Profiling Services Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.28 Proteome Profiling Services Market, 2020-2030: COVID Impact Scenario (USD Billion)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook